- Professor Hardy elected member of EMBO
- Working with Saracens to monitor concussion in rugby
- Mutations in two novel genes cause primary dystonia
- A new genetic switch uncovered in the long genes expressed in our brain
- Professor Alan Thompson elected to the Fellowship of the Academy of Medical Sciences
- UCL Institute of Neurology researchers awarded MRC fellowships
- Professor Ray Dolan has been elected Member of the European Academy of Sciences and Arts
- Deep brain stimulation for Tourette syndrome
- Behaviour changes common in early stage familial Alzheimer's
- Imaging shows early brain changes in FTD patients
- New test measures deadly protein in Huntington’s disease patients’ spinal fluid
- Professor Mary Reilly is elected to be the first female President of the Association of British Neurologists in 83 years
- Structure of genetic messenger molecules reveals key role in diseases
- Professor Nick Fox speaks about trial in early onset familial Alzheimer's disease at UCL
- First major exhibition to explore BSE and its impact opens at Hayward Gallery
- Government pledges £300m for dementia research
- UCL awarded £10m to develop new dementia treatments
- BRC awards £700,000 to neuroscience projects
- UCL Neuroscience rated top by research strength in the REF2014
- $5.9 million boost for SUDEP research
- Secret of tetanus toxicity offers new way to treat motor neuron disease
- Harm to others outweighs harm to self in moral decision making
- Auto anomaly detection for brain imaging awarded £1m grant
- Spinal surgery: OECs studies to start in 2015
- New brain tumour research Centre of Excellence is unveiled
- UCL awarded £13.5 million to advance medical research facilities
- UCL research helps paralysed man to recover function
- Stenting safe and effective for long-term stroke prevention
- Department of Clinical & Experimental Epilepsy re-designated as a WHO Collaborating Centre
- Leonard Wolfson Experimental Neurology Centre open evening
- Brain stimulation to improve cognition in dementia
- Professor Lees receives Jay Van Andel Award for Outstanding Research in Parkinson’s Disease
- Creating brain cells from skin to study Alzheimer's
- Queen Square authors prominent in Brain collection of classic articles
- Toxic proteins implicated in frontotemporal dementia and motor neurone disease
- GCH1 gene and Parkinson’s risk
- Double mutation linked to frontotemporal dementia
- Equation to predict happiness
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- Teaching Awards 2015
Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
4 March 2014
Dame Sally Davies, the Chief Medical Officer, has appointed Professor Martin Rossor (UCL Institute of Neurology) as the new NIHR National Director for Dementia Research.
This new post will provide the leadership needed to facilitate and support the Department of Health’s research response to commitments under the Prime Minister’s Dementia Challenge and the G8 Dementia Summit. This will involve activity across NIHR activity as well as work with single components of NIHR. Other work will involve engagement with external stakeholders, such as NHS England, research charities and other research funders, including industry. Martin will draw on the expertise of the Evington Group, and work with the Dementia Innovation Envoy.
Professor Rossor will work closely with staff in the DH R&D Directorate, with the NIHR Clinical Research Network, particularly Jonathan Sheffield and Ian McKeith, and with other NIHR research infrastructure, especially Simon Lovestone and the NIHR Dementia Translational Research Collaboration, as well as Alistair Burns, NHS England’s National Clinical Director for Dementia.
The initial focus of effort will be on:
1. International Action Plan: Contributing to the development of an international action plan for research, which will account for the current state of science and promote global efforts to maintain brain health and find therapies for dementia.
2. Championing research: Working with clinical academics and the NHS.
3. Patients and their data: Improving recruitment of patients into research through building on the NHS Constitution pledge to inform patients about opportunities to participate in research and engaging the NHS in the implementation of RAFT (the Recruitment & Feasibility Tool – a database for patients to register their interest in dementia research).
4. Facilitating clinical research: Working with the Translational Research Collaboration and the NIHR Clinical Research Network towards achieving common research platforms; working within current frameworks for consent and use of data to promote sharing of data from existing research.
5. Living Well with Dementia: Facilitating research to support living well with dementia initiatives and identifying effective interventions, in the clinic, in the nursing home, and in everyday life.
6. Building research capacity and addressing other barriers to research progress.
The responsibility for the research and infrastructure funded by NIHR will remain with individuals leading the research and the relevant NIHR initiatives.
Martin will be supported by a small staff.
Page last modified on 04 mar 14 10:03